BNP Paribas Financial Markets’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Sell
40,000
-1,358
-3% -$55.1K ﹤0.01% 1954
2025
Q1
$1.81M Sell
41,358
-101,500
-71% -$4.45M ﹤0.01% 1733
2024
Q4
$6.14M Sell
142,858
-6,561
-4% -$282K ﹤0.01% 1146
2024
Q3
$6.63M Buy
149,419
+101,000
+209% +$4.48M ﹤0.01% 921
2024
Q2
$1.93M Sell
48,419
-8,809
-15% -$350K ﹤0.01% 1371
2024
Q1
$2.47M Buy
57,228
+570
+1% +$24.6K ﹤0.01% 1408
2023
Q4
$2.36M Buy
56,658
+51,561
+1,012% +$2.15M ﹤0.01% 1318
2023
Q3
$203K Sell
5,097
-1,211
-19% -$48.1K ﹤0.01% 2420
2023
Q2
$259K Buy
6,308
+903
+17% +$37K ﹤0.01% 2308
2023
Q1
$222K Buy
5,405
+677
+14% +$27.8K ﹤0.01% 2490
2022
Q4
$194K Buy
4,728
+867
+22% +$35.5K ﹤0.01% 2360
2022
Q3
$155K Buy
3,861
+352
+10% +$14.1K ﹤0.01% 2896
2022
Q2
$147K Sell
3,509
-866
-20% -$36.4K ﹤0.01% 2584
2022
Q1
$198K Buy
4,375
+651
+17% +$29.5K ﹤0.01% 2576
2021
Q4
$172K Sell
3,724
-99,979
-96% -$4.61M ﹤0.01% 2803
2021
Q3
$4.92M Buy
103,703
+280
+0.3% +$13.3K 0.01% 946
2021
Q2
$5.35M Buy
103,423
+100,423
+3,347% +$5.2M 0.01% 911
2021
Q1
$151K Hold
3,000
﹤0.01% 2614
2020
Q4
$156K Buy
3,000
+1,000
+50% +$52.1K ﹤0.01% 2354
2020
Q3
$87K Hold
2,000
﹤0.01% 2581
2020
Q2
$86K Buy
+2,000
New +$86K ﹤0.01% 2205
2020
Q1
Sell
-850,000
Closed -$38.8M 3752
2019
Q4
$38.8M Buy
+850,000
New +$38.8M 0.07% 144
2019
Q1
Sell
-208,000
Closed -$7.62M 3718
2018
Q4
$7.62M Buy
208,000
+8,000
+4% +$293K 0.02% 446
2018
Q3
$9.71M Hold
200,000
0.01% 583
2018
Q2
$8.6M Hold
200,000
0.01% 581
2018
Q1
$8.37M Buy
+200,000
New +$8.37M 0.02% 519
2017
Q4
Sell
-100,000
Closed -$4.26M 3574
2017
Q3
$4.26M Hold
100,000
0.01% 783
2017
Q2
$4.3M Hold
100,000
0.01% 769
2017
Q1
$4.18M Buy
+100,000
New +$4.18M 0.01% 755